{"transactions":[{"id":1853248,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":112241,"kind":"person","name":"Thompson Jeffery S","position":1,"cik":"0001510398","reported_name":"Thompson Jeffery S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:17:11.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2024 annual meeting of the Company's stockholders or June 14, 2024."}],"balance_after":31575,"source":{"system":"sec-edgar","filing":"0001171843-23-003962","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184323003962/ownership.xml","form_type":"4"}},{"id":2236777,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":112241,"kind":"person","name":"Thompson Jeffery S","position":1,"cik":"0001510398","reported_name":"Thompson Jeffery S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-10T20:15:52.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":7954,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on the earlier of the 2023 annual meeting of the Company's stockholders or June 8, 2023."}],"balance_after":25075,"source":{"system":"sec-edgar","filing":"0001171843-22-004297","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184322004297/ownership.xml","form_type":"4"}},{"id":2334265,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":112241,"kind":"person","name":"Thompson Jeffery S","position":1,"cik":"0001510398","reported_name":"Thompson Jeffery S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-15T13:00:49.000Z","date":"2022-03-11","kind":"purchase","acquired":true,"shares":2000,"price":24.659,"value":49318.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 11, 2022, Mr. Thompson purchased 2,000 shares in multiple trades ranging from $24.53 to $24.70. The price reported above reflects the weighted average purchase price. Mr. Thompson undertakes to provide the Securities and Exchange Commission staff, the issuer, or any security holder, upon request, full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":17121,"source":{"system":"sec-edgar","filing":"0001171843-22-001878","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184322001878/ownership.xml","form_type":"4"}},{"id":2662153,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":112241,"kind":"person","name":"Thompson Jeffery S","position":1,"cik":"0001510398","reported_name":"Thompson Jeffery S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-21T20:19:02.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":4172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on the earlier of the 2022 annual meeting of the Company's stockholders or June 16, 2022."}],"balance_after":15121,"source":{"system":"sec-edgar","filing":"0001171843-21-004430","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184321004430/ownership.xml","form_type":"4"}},{"id":3244741,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":112241,"kind":"person","name":"Thompson Jeffery S","position":1,"cik":"0001510398","reported_name":"Thompson Jeffery S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-27T23:47:32.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":4107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on February 25, 2021."}],"balance_after":10949,"source":{"system":"sec-edgar","filing":"0001171843-20-001356","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184320001356/ownership.xml","form_type":"4"}},{"id":3441635,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":112241,"kind":"person","name":"Thompson Jeffery S","position":1,"cik":"0001510398","reported_name":"Thompson Jeffery S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-12T20:06:16.000Z","date":"2019-08-08","kind":"sale","acquired":false,"shares":4843,"price":56.66,"value":274404.38,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sales price. The shares were sold on 8/8/19 at prices ranging from $56.65 to $56.75 per share. Full information regarding the number of shares sold at each price shall be provided to the Staff, Issuer or any security holder, upon request."}],"balance_after":6842,"source":{"system":"sec-edgar","filing":"0001171843-19-005414","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184319005414/ownership.xml","form_type":"4"}},{"id":3627464,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":112241,"kind":"person","name":"Thompson Jeffery S","position":1,"cik":"0001510398","reported_name":"Thompson Jeffery S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-28T21:36:06.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":3842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on February 26, 2020."}],"balance_after":11685,"source":{"system":"sec-edgar","filing":"0001171843-19-001391","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184319001391/ownership.xml","form_type":"4"}},{"id":4088838,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":112241,"kind":"person","name":"Thompson Jeffery S","position":1,"cik":"0001510398","reported_name":"Thompson Jeffery S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-26T21:10:22.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":1626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on January 24, 2019."}],"balance_after":7843,"source":{"system":"sec-edgar","filing":"0001171843-18-000696","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184318000696/formfour.xml","form_type":"4"}},{"id":4308945,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":112241,"kind":"person","name":"Thompson Jeffery S","position":1,"cik":"0001510398","reported_name":"Thompson Jeffery S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-23T20:56:51.000Z","date":"2017-05-22","kind":"sale","acquired":false,"shares":9628,"price":47.37,"value":456078.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold on 5/22/2017 at prices ranging from $47.25 to $47.45 per share. Full information regarding the number of shares sold at each price shall be provided to the Staff, Issuer or any security holder, upon request."}],"balance_after":6217,"source":{"system":"sec-edgar","filing":"0001171843-17-003274","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317003274/formfour.xml","form_type":"4"}},{"id":4308944,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":112241,"kind":"person","name":"Thompson Jeffery S","position":1,"cik":"0001510398","reported_name":"Thompson Jeffery S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-23T20:56:51.000Z","date":"2017-05-19","kind":"sale","acquired":false,"shares":1097,"price":47.58,"value":52195.26,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sales price. The shares were sold on 5/19/2017 at prices ranging from $47.56 to $47.61 per share. Full information regarding the number of shares sold at each price shall be provided to the Staff, Issuer or any security holder, upon request."}],"balance_after":15845,"source":{"system":"sec-edgar","filing":"0001171843-17-003274","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317003274/formfour.xml","form_type":"4"}},{"id":4475948,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":112241,"kind":"person","name":"Thompson Jeffery S","position":1,"cik":"0001510398","reported_name":"Thompson Jeffery S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-31T21:10:34.000Z","date":"2017-01-27","kind":"grant","acquired":true,"shares":1994,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares represent restricted stock units.  Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock.  The restricted stock units vest in full on January 27, 2018."}],"balance_after":16942,"source":{"system":"sec-edgar","filing":"0001171843-17-000591","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317000591/formfour.xml","form_type":"4"}}]}